Assesses oncotype score and its impact on response duration to first-line CDK4/6 inhibitors in metastatic breast cancer patients, suggesting its potential for prognostication.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
King-Oakley et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: